Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
Future Fuel
FF
$217M
| $97.8K | ﹤0.01% |
13,258
+765
| +6% | +$6.58K |
|
4052
INNOVATE Corp
VATE
$111M
| $97.7K | ﹤0.01% |
+3,288
| New | +$96.1K |
|
|
KALV
4053
DELISTED
KalVista Pharmaceuticals
KALV
| $97.6K | ﹤0.01% |
12,413
+5,841
| +89% | +$43.6K |
|
4054
Identive
INVE
$63.4M
| $97.5K | ﹤0.01% |
15,883
+5,295
| +50% | +$39K |
|
4055
Tucows
TCX
$172M
| $97.5K | ﹤0.01% |
5,011
+2,350
| +88% | +$67.8K |
|
|
FAZ
4056
DELISTED
Direxion Daily Financial Bear 3x ETF
FAZ
| $97K | ﹤0.01% |
440
+35
| +9% | +$6.5K |
|
4057
Sight Sciences
SGHT
$286M
| $96.7K | ﹤0.01% |
11,059
+5,209
| +89% | +$57.8K |
|
4058
Richmond Mutual Bancorp
RMBI
$251M
| $96.4K | ﹤0.01% |
9,295
| – | – |
|
|
CLCO
4059
DELISTED
Cool Company
CLCO
| $96.3K | ﹤0.01% |
+8,002
| New | +$97.9K |
|
4060
Dakota Gold
DC
$608M
| $96.1K | ﹤0.01% |
26,537
+12,510
| +89% | +$41.4K |
|
4061
908 Devices
MASS
$329M
| $96.1K | ﹤0.01% |
11,169
+4,983
| +81% | +$44.5K |
|
4062
Blend Labs
BLND
$431M
| $95.9K | ﹤0.01% |
96,250
+45,420
| +89% | +$69.6K |
|
4063
Foster
FSTR
$430M
| $95.8K | ﹤0.01% |
8,345
| – | – |
|
4064
Universal Electronics
UEIC
$57.8M
| $95.8K | ﹤0.01% |
9,447
+283
| +3% | +$4.93K |
|
|
JBIO
4065
Jade Biosciences
JBIO
$1.2B
| $95.2K | ﹤0.01% |
135
+24
| +22% | +$19.9K |
|
4066
Freshworks
FRSH
$3.14B
| $95.1K | ﹤0.01% |
6,194
+4,201
| +211% | +$63.6K |
|
|
PAMT
4067
PAMT Corp
PAMT
$337M
| $95.1K | ﹤0.01% |
3,320
+1,550
| +88% | +$43.7K |
|
|
IIF
4068
Morgan Stanley India Investment Fund
IIF
$217M
| $95K | ﹤0.01% |
4,000
| – | – |
|
|
SACH
4069
Sachem Capital Corp
SACH
$39.1M
| $94.8K | ﹤0.01% |
+25,474
| New | +$93.7K |
|
4070
Caledonia Mining Corp
CMCL
$355M
| $94.5K | ﹤0.01% |
6,220
+3,627
| +140% | +$50.8K |
|
|
CVLY
4071
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $94.4K | ﹤0.01% |
4,548
+4,294
| +1,691% | +$102K |
|
4072
monday.com
MNDY
$3.68B
| $94.4K | ﹤0.01% |
661
-215
| -25% | -$29.1K |
|
|
HEPS
4073
D-Market Electronic Services & Trading
HEPS
$1.05B
| $93.8K | ﹤0.01% |
70,000
| – | – |
|
|
GOEV
4074
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $93.7K | ﹤0.01% |
312
+192
| +160% | +$81.4K |
|
4075
Ocugen
OCGN
$416M
| $93.7K | ﹤0.01% |
109,802
-1,177,086
| -91% | -$1.28M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.